Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 611 through 620 of 961 results (Download Results)

Show results per page

COVID-19 Variant Supplement – The COVID‑19 Ontario Pregnancy Event (COPE) Network: Assessing the impact of COVID‑19 in pregnancy on maternal, fetal and newborn health

El-Chaar, Darine | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

Unpacking COVID‑19 Vaccine Hesitancy in Canada

Dubé, Eve | Université Laval | Operating Grant | $499,870

CIHR Quebec 2021

COVID-19 Variant Network – Implementation of serological and molecular tools to inform COVID‑19 patient management

Lerner-Ellis, Jordan P | Sinai Health System | Operating Grant | $100,000

CIHR Ontario 2021

Substance use disorder treatment transformations due to the COVID‑19 pandemic: Impact on Indigenous patients and communities

Wendt, Dennis C | McGill University | Operating Grant | $167,124

CIHR Quebec 2020

Deciphering immune responses in COVID‑19 patients to identify immune correlates of protection and susceptibility for targeted therapeutics

Elahi, Shokrollah | University of Alberta | Project Grant | $1,071,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $44,460

CIHR Ontario 2021

Tracking the Prevalence and Incidence of Modifiable Suicide Risk Factors During the COVID‑19 Pandemic to Inform Targeted Suicide Prevention in British Columbia

Turner, Brianna J | University of Victoria | Operating Grant | $189,894

CIHR British Columbia 2020

Canadian Longitudinal Study on Aging (CLSA): Building COVID‑19 Platform for Research in Canada

Raina, Parminder S | McMaster University | Operating Grant | $1,199,987

CIHR Ontario 2020

COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

Ng, Kenneth K | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

Wilson, Joyce A | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – The COVID‑19 Ontario Pregnancy Event (COPE) Network: Assessing the impact of COVID‑19 in pregnancy on maternal, fetal and newborn health

Unpacking COVID‑19 Vaccine Hesitancy in Canada

COVID-19 Variant Network – Implementation of serological and molecular tools to inform COVID‑19 patient management

Substance use disorder treatment transformations due to the COVID‑19 pandemic: Impact on Indigenous patients and communities

Deciphering immune responses in COVID‑19 patients to identify immune correlates of protection and susceptibility for targeted therapeutics

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Tracking the Prevalence and Incidence of Modifiable Suicide Risk Factors During the COVID‑19 Pandemic to Inform Targeted Suicide Prevention in British Columbia

Canadian Longitudinal Study on Aging (CLSA): Building COVID‑19 Platform for Research in Canada

COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.